Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 20, 1998

Primary Completion Date

April 18, 2007

Study Completion Date

April 18, 2007

Conditions

Lymphoma

Interventions

BIOLOGICAL

filgrastim

DRUG

cyclophosphamide

DRUG

cytarabine

DRUG

dexamethasone

DRUG

doxorubicin hydrochloride

DRUG

methotrexate

DRUG

vincristine sulfate

Trial Locations (1)

University of Texas - MD Anderson Cancer Center, Houston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT00003311 - Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma | Biotech Hunter | Biotech Hunter